Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D N Buell

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1974
Insulin-dependent regulation of insulin receptor concentrations: a direct demonstration in cell cultureJ R Gavin, J Roth, D M Neville, et al.
The New England Journal of Medicine|April 18, 1974
Bone-resorbing activity in supernatants from lymphoid cell linesG R Mundy, R A Luben, L G Raisz, et al.
Journal of Clinical Pharmacology|September 11, 2001
Pharmacokinetics, excretion, and mass balance of 14C after administration of 14C-cholesterol-labeled AmBisome to healthy volunteersI Bekersky, R M Fielding, D E Dressler, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2001
Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose studyT J Walsh, J L Goodman, P Pappas, et al.
CA: a Cancer Journal for Clinicians|September 1, 1979
Clinical Oncology Program: a community cancer control modelW M Dugan, D J Minnick, J R Wood, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 17, 2009
Factors related to survival and treatment success in invasive candidiasis or candidemia: a pooled analysis of two large, prospective, micafungin trialsD L Horn, L Ostrosky-Zeichner, M I Morris, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 7, 1999
Tacrolimus vs. cyclosporine immunosuppression: results in advanced-stage disease compared with historical controls treated exclusively with cyclosporineM M Horowitz, D Przepiorka, P Bartels, et al.
Annals of Internal Medicine|April 1, 1993
Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trialD J Winston, P H Chandrasekar, H M Lazarus, et al.
Clinical Pharmacology and Therapeutics|November 6, 2009
Safety and pharmacokinetics of repeat-dose micafungin in young infantsD K Benjamin, P B Smith, A Arrieta, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 2, 2005
International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemiaL Ostrosky-Zeichner, D Kontoyiannis, J Raffalli, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1974
Insulin-dependent regulation of insulin receptor concentrations: a direct demonstration in cell cultureJ R Gavin, J Roth, D M Neville, et al.
The New England Journal of Medicine|April 18, 1974
Bone-resorbing activity in supernatants from lymphoid cell linesG R Mundy, R A Luben, L G Raisz, et al.
Journal of Clinical Pharmacology|September 11, 2001
Pharmacokinetics, excretion, and mass balance of 14C after administration of 14C-cholesterol-labeled AmBisome to healthy volunteersI Bekersky, R M Fielding, D E Dressler, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2001
Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose studyT J Walsh, J L Goodman, P Pappas, et al.
CA: a Cancer Journal for Clinicians|September 1, 1979
Clinical Oncology Program: a community cancer control modelW M Dugan, D J Minnick, J R Wood, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 17, 2009
Factors related to survival and treatment success in invasive candidiasis or candidemia: a pooled analysis of two large, prospective, micafungin trialsD L Horn, L Ostrosky-Zeichner, M I Morris, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 7, 1999
Tacrolimus vs. cyclosporine immunosuppression: results in advanced-stage disease compared with historical controls treated exclusively with cyclosporineM M Horowitz, D Przepiorka, P Bartels, et al.
Annals of Internal Medicine|April 1, 1993
Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trialD J Winston, P H Chandrasekar, H M Lazarus, et al.
Clinical Pharmacology and Therapeutics|November 6, 2009
Safety and pharmacokinetics of repeat-dose micafungin in young infantsD K Benjamin, P B Smith, A Arrieta, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 2, 2005
International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemiaL Ostrosky-Zeichner, D Kontoyiannis, J Raffalli, et al.
Pageof 4